Let's talk about Min-102 results from ALD news.

[artortega78]

adrenoleukodystrophynews.co...

Men who have Early-onset AMN will improve their walking or stay the same. Min-102 reduces the risk of Men developing AMN with cerebral ALD by 5 times. We need to reduce the Mortality of all ALD patients in the future.

[BMDproductions]

it sounds promising... all patients should be taking it

[artortega78 in reply to BMDproductions]

I agree, so we can reduce mortality by a lot.

[wilburlois15]

We're now in the next phase of the trial, where all participants are on the drug. As far as I understand it, there is no end date and they will continue to collect data regarding mobility and balance. At some point, individual health authorities need to take a decision on whether to provide the drug based on the evidence we have. Hopefully they will say yes.

[SongStream in reply to wilburlois15]

The data will also include adult cerebral ALD.